Linagliptin & Metformin Hydrochloride "'"

Linagliptin & Metformin Hydrochloride
LINALIGLIP 2.5/500  
Linagliptin is an oral medication that belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. Incretin hormones are responsible for increasing insulin release and decreasing glucagon secretion, both of which help regulate blood sugar levels. By inhibiting DPP-4, linagliptin prolongs the action of these incretin hormones, leading to improved blood sugar control. It is usually taken once a day and can be used alone or in combination with other diabetes medications.
Metformin Hydrochloride is one of the most commonly prescribed medications for type 2 diabetes. It belongs to the class of drugs known as biguanides. Metformin works by reducing the amount of glucose produced by the liver and improving insulin sensitivity in muscle cells. It also has some effects on slowing down the absorption of glucose from the intestines. Metformin is often the first-line treatment for type 2 diabetes and can be used alone or in combination with other medications.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-2-5-500-134273